Intranasal Covid-19 Vaccine: Bharat Biotech Set To Begin Phase 1 Trials By Feb-Mar

1:22 AM
Phase-1 clinical trials of Hyderabad based Bharat Biotech's new intranasal antidote for Coronavirus will begin during February-March this year.

from covid-19 https://ift.tt/3ovvxKb

Post a Comment

No comments

Subscribe to: Post Comments ( Atom )
Powered by Blogger.